Properties of the first human cell line derived human recombinant factor VIII

被引：0
|
作者：
Sandberg, H. [1 ]
Agerkvist, I. [1 ]
Dadaian, M. [1 ]
Ramstrom, M. [1 ]
Sebring, S. [1 ]
Stenlund, P. [1 ]
机构：
[1] Octapharma AB, Biopharmaceut, Prod Dev, SE-11275 Stockholm, Sweden
来源：
HAEMOPHILIA | 2009年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：633 / 633
页数：1
相关论文
共 50 条
  • [1] The first recombinant human coagulation factor VIII of human origin: human cell line and manufacturing characteristics
    Casademunt, Elisabeth
    Martinelle, Kristina
    Jernberg, Mats
    Winge, Stefan
    Tiemeyer, Maya
    Biesert, Lothar
    Knaub, Sigurd
    Walter, Olaf
    Schroeder, Carola
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (02) : 165 - 176
  • [2] Characteristics of the first human cell line recombinant human factor VIII (human-cl rhFVIII)
    Sandberg, H.
    Agerkvist, I
    Kannicht, C.
    Ramstrom, M.
    Stenlund, P.
    Dadaian, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 513 - 514
  • [3] The First Human Cell Line Recombinant Factor VIII (Human-cl rhFVIII) - Functional Properties and Differences From Currently Available Recombinant Factor VIII Products.
    Schwartz, Bruce A.
    Sandberg, Helena
    Agerkvist, Irene
    Kannicht, Christoph
    Ramstrom, Margareta
    Stenlund, Peter
    Oswaldsson, Ulla
    Brunberg, Tobias
    [J]. BLOOD, 2009, 114 (22) : 532 - 532
  • [4] A novel recombinant factor VIII expressed in a human cell line
    Sandberg, H.
    Agerkvist, I.
    Lindner, E.
    Martinelle, K.
    Winge, S.
    [J]. HAEMOPHILIA, 2008, 14 : 15 - 15
  • [5] Pharmacokinctic, efficacy and safety data of the first recombinant factor VIII from a human cell line
    Knaub, S.
    Jansen, M.
    Zozulya, N.
    Plyushch, O.
    [J]. HAEMOPHILIA, 2010, 16 : 31 - 31
  • [6] Characterisation of the post-translational modifications of a novel, human cell line-derived recombinant human factor VIII
    Kannicht, Christoph
    Ramstrom, Margareta
    Kohla, Guido
    Tiemeyer, Maya
    Casademunt, Elisabeth
    Walter, Olaf
    Sandberg, Helena
    [J]. THROMBOSIS RESEARCH, 2013, 131 (01) : 78 - 88
  • [7] Final pharmacokinetic, efficacy and safety data of the first recombinant factor VIII from a human cell line
    Zozulya, N.
    Jansen, M.
    Plyushch, O.
    Knaub, S.
    [J]. HAEMOPHILIA, 2011, 17 (02) : 357 - 357
  • [8] Product characteristics of human cell line recombinant factor VIII, (human-cl rhFVIII)
    Sandberg, H.
    Ramstrom, M.
    Stenlund, P.
    Kannicht, C.
    Agerkvist, I.
    [J]. HAEMOPHILIA, 2010, 16 : 39 - 39
  • [9] Product characteristics of human cell line recombinant factor VIII (human-cl rhFVIII)
    Sandberg, H.
    Ramstrom, M.
    Stenlund, P.
    Kannicht, C.
    Agerkvist, I.
    [J]. HAEMOPHILIA, 2011, 17 (02) : 356 - 357
  • [10] Enhancing the pharmacokinetic properties of recombinant factor VIII: A first human dose trial with GlycoPEGylated recombinant factor VIII in patients with hemophilia A
    Tiede, A.
    Brand, B.
    Fisher, R.
    Kavakli, K.
    Lentz, S.
    Matsushita, T.
    Rea, C.
    Viuff, D.
    [J]. HAEMOPHILIA, 2012, 18 : 22 - 22
12345